Category: Myelodysplastic Syndrome

Asunercept (APG101) is a Selective CD95L Inhibitor for Glioblastoma Research

Glioblastoma is the most frequent and aggressive form of brain tumour. Significantly, the highly invasive growth of these tumors often prevents complete surgical resection. Consequently, patients progress shortly after surgery. In fact, clinical evidence confirms CD95L as a promising novel target for the treatment of recurrent glioblastoma and potentially...

Olutasidenib is a Mutant IDH1 Inhibitor for the Treatment of AML or MDS

Acute myeloid leukemia (AML) is a kind of cancer diseases, a cancer of the myeloid line of blood cells. AML seriously affects patients’ life as we previously mentioned in our blog. Thus, it is necessary to find out more anti-acute myeloid leukemia agents. As we all konw, IDH (Isocitrate...